Carl-Henric Heldin, Staffan Johansson and Gunnar Pejler have been awarded a total of 10.6 million SEK by the Swedish Cancer Society, Cancerfonden

2019-11-21

Cancerfonden has decided to give an additional SEK 670 million to Swedish cancer research. This means that the Swedish Cancer Society decided this year on a record dividend of SEK 770 million. It is the largest amount in the history of the Swedish Cancer Society.

Research projects that will receive funding for their research are:
Carl-Henrik Heldin, Uppsala universitet, PDGF receptor signaling - importance of receptor trafficking and localization, 2020-01-01 - 2022-12-31, 3 år x 1 250 000 Skr

Staffan Johansson, Uppsala universitet, CYTOKINESIS AS A CANCER-SPECIFIC TARGET, 2020-01-01 - 2022-12-31, 3 år x 800 000 Skr

Sven Pejler, Uppsala universitet, The role of mast cells in cancer- experimental and clinical aspects, 2020-01-01 - 2022-12-31, 3 år x 1 500 000 Skr

Read more about the Swedish Cancer Society, Cancerfonden (only in Swedish)

Nyheter